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ABSTRACT
This study discusses the effect of complexes of chitosan grafted polyethylenimine(Ch-PEI) with plasmid
DNA on viability of mesenchymal stem cells(MSCs) derived from human marrow. Ch-PEI/pDNA
nanoparticles were synthesized through the complex coacervation method using pIRES plasmid containing
Green Fluorescent Protein (GFP) gene. To confirm the complexation, samples were run through an agarose
gel. Human bone marrow mesenchymal stem cells were studied for the cytotoxicity of the nanoparticles by
MTT assay. MTT results indicated Ch-PEI does not have any significant cytotoxicity compared with PEI
and Lipofectamine2000 leading to 40% cytotoxicity. According to the results it seems that grafting chitosan
with PEI improves the MSCs viability.
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INTRODUCTION
Mesenchymal stem cells are clonogenic and
nonhematopoeitic cells in bone marrow with the
ability of differentiating to different mesodermal
cells such as osteoblast, chondrocyte and
endothelial cells and even nonmesodermal cells
such as neurons. They are the first stem cells used
in clinical application because of their wide
differentiating potential. Their low
immunogenecity caused them to be used allogene
[1]. Transfecting of some genes could lead to a
better differentiation potential for example
transfecting of TGF- gene could lead to
chondrogenic differentiation or hTERT gene
could enhance the proliferation [2,3]. But the
important obstacle is the selection of the best
procedure for gene transfection. in a perfect gene
delivery system ,the vector should be nontoxic
and nonimmunogenic [4], should be small enough
to enter nucleous [5].
Gene delivery vectors divide into two groups:
Viral and nonviral but the simplest approach is
using of naked DNA. Direct injection of naked
DNA in some tissues such as muscle shows a high
level of expression [6]. Although it causes gene
expression but its expression level is so less than
viral or liposomal vectors. Transfection efficiency
will be higher using viral vectors. But also there
are some defects that limited their clinical
application.The first and most important problem
[7]. Viral vectors could only
transfer small sizes of DNA. They are mutagen
and oncogen [8,9].
Nonviral vectors could be administered frequently
with minimum immune response. Targetability,
stability during storage and ease of production are
some of their advantages [10]. Cationic lipids and
cationic polymers are the two main types of
nonviral vectors.They both interact negativley
charged DNA with electrostatic bonds through
their positive charge and compose complexes.
Cationic polymers condense DNA and inhibit
their degradation by nucleases. The most
impportant feature is their low toxicity7 but in
